Financials
- Market Capitalization 1.91 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.91
Fiyat/satışlar oranı
12.18
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1953 | FTRE Fortrea Holdings Inc. - Common Stock | 21.00 USD | +0.77% | -4.55% | +21.95% | +103.49% | 2.00 B USD | ||
| 1961 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 22.23 USD | -4.88% | -5.56% | -21.00% | -44.93% | 1.97 B USD | ||
| 1978 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 10.46 USD | -0.19% | +2.25% | +37.81% | +30.75% | 1.91 B USD | ||
| 1990 | URGN UroGen Pharma Ltd. - Ordinary Shares | 38.28 USD | +3.94% | -11.47% | -9.63% | +101.47% | 1.87 B USD |